AI Diagnostics Take Over Veterinary Practices – I Expect New All-Time Highs at IDEXX Laboratories

IDEXX sees global market potential of over $45 billion for pet diagnostics. Blood tests are only performed for 13% of US preventative appointments.
Andreas Zehetner
A. Zehetner
Reading Time: 2 minutes

The jump in the stock price of nearly 22% following the figures from November 2 underscores why I count IDEXX Laboratories (IDXX) among my new favorites among the long-term stocks. The company is transferring the AI healthcare story to veterinary medicine. Dogs and cats from the pandemic boom are getting older, and their diagnostic needs are increasing. At the same time, early detection opens up new examination opportunities. IDEXX can therefore grow even without an increase in veterinary visits. What I particularly like is the interplay of the...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In